The cleanup process that keeps ordinary cell death from becoming inflammation, and what happens when it begins to fail

Billions of your cells will die today. You will probably notice none of them. That may be one of the more remarkable facts about being alive.

Cell death sounds catastrophic because we tend to encounter the word in catastrophic settings. A heart attack kills heart muscle. A stroke kills neurons. Cancer treatment kills tumor cells. But most cell death is nothing like this. It is planned, orderly, and so routine that your tissues depend on it.

Cells age. They become damaged. They finish the jobs they were built to do. Then many activate a carefully controlled program called apoptosis and dismantle themselves. The remarkable part is what happens next. Your body does not simply leave the remains where they fall. It eats them.

Death Without an Alarm

For much of my career in oncology, I have thought about cell death as an objective. Radiation damages cancer cells precisely because we want those cells to stop surviving and reproducing. But killing a cell is only part of the biological story. Someone has to deal with what remains.

This is harder than it sounds. A dying cell contains proteins, DNA, enzymes, membranes, and other material that should not simply spill into the surrounding tissue. If enough intracellular debris escapes uncontrolled, the immune system can interpret the scene as damage and respond with inflammation.

Apoptosis solves part of that problem by allowing a cell to die relatively neatly. The cell shrinks, reorganizes its contents, and packages material rather than simply bursting apart. Then another system takes over. Its name is efferocytosis, from a Latin root meaning to carry to the grave. It is the process by which macrophages and other cells recognize, engulf, and dispose of dying cells. Researchers increasingly view it not merely as garbage collection but as an active part of resolving inflammation and maintaining tissue homeostasis.

The distinction matters. Your immune system does not merely need to know when to attack. It also needs to know when to stop.

The Dead Cell Sends a Message

A cell preparing to disappear does something surprisingly social. It communicates. Dying cells can release molecular signals that attract scavenging cells toward them. Once a macrophage arrives, changes on the dying cell’s surface help identify it as something that should be removed rather than attacked.

One of the best-known changes involves phosphatidylserine, a lipid normally kept largely on the inner side of the cell membrane. During apoptosis, it becomes exposed on the outer surface. In biological terms, it functions something like a flag: I am finished. Remove me.

A macrophage recognizes these signals, surrounds the dying cell, and swallows it. But this is where the story becomes much more interesting than waste disposal. The act of consuming a dying cell can change the macrophage itself. Its metabolism and signaling shift. Rather than simply eliminating debris, the macrophage can move toward programs associated with resolving inflammation and repairing tissue. Recent work continues to reveal how deeply this cleanup process is intertwined with macrophage metabolism.

The janitor does not merely clean the room. Cleaning changes the janitor.

What Happens When Cleanup Slows

This system is extraordinarily efficient, which is why most of us have never heard of it. We tend to notice biological systems only when they fail.

When apoptotic cells are not removed promptly, their orderly death can become less orderly. Membranes eventually lose integrity. Material that had been contained can escape. Signals that should have ended quietly can become inflammatory. That possibility has made efferocytosis increasingly interesting to researchers studying chronic inflammatory disease.

A 2025 review focused specifically on aging described evidence that the machinery of efferocytosis changes as phagocytic cells age and that impaired clearance interacts with several hallmarks of aging, including mitochondrial dysfunction, cellular senescence, altered communication between cells, and chronic inflammation. That does not mean defective efferocytosis is the cause of aging. Biology almost never gives us explanations that convenient. It means something subtler: one reason inflammation may become harder to resolve with age could involve not only how vigorously the immune system responds to damage, but how efficiently it cleans up afterward.

And that changes the question. Instead of asking only why inflammation starts, researchers can also ask why it sometimes fails to end.

Scientists Are Finding the Cleanup System Everywhere

Over the past year, that question has produced some striking results. In 2025, researchers studying newborn and adult hearts found that macrophages in newborn tissue were particularly equipped for efferocytosis after injury. Engulfing dying cells altered macrophage metabolism in ways that helped promote tissue regeneration. Adult tissues did not reproduce the same response as effectively.

Other researchers have found connections in very different tissues. A 2025 Nature study showed that limited death of pancreatic beta cells could remodel macrophages in the pancreatic islets through efferocytosis. In osteoarthritis models, investigators reported that high glucose could impair macrophage efferocytosis through a specific molecular mechanism and worsen disease progression. In 2026, researchers reported that macrophage efferocytosis can promote inflammation resolution and accelerate wound healing. Another study found that efferocytosis enhanced macrophage functions involved in blood-vessel formation during bone-marrow regeneration.

But perhaps the most striking recent finding came in 2026. Researchers found that restoring the ability of tissue-resident macrophages to clear senescent neutrophils improved multiple signs of aging in mice, including frailty, muscle loss, cognitive decline, cardiac dysfunction, and systemic inflammation. The mechanism involved blocking a specific inflammatory signaling pathway in aging macrophages. The researchers also found evidence of related changes in aged human tissues, although whether the same intervention could restore clearance in people remains unknown. Still, the finding raises a provocative possibility: at least some of the decline in this hidden cleanup system may be reversible rather than inevitable.

Different organs. Different diseases. Different experimental systems. The recurring idea is that disposing of a dead cell is not necessarily the end of a biological event. Sometimes it helps determine what happens next.

The Part of Healing We Rarely Think About

Medicine naturally focuses on threats. Kill the bacterium. Remove the tumor. Suppress the inflammation. Repair the injury. Those verbs make sense because disease announces itself through disruption.

But healthy physiology depends just as much on what happens after disruption. A fever must come down. An immune response must retreat. Damaged material must be removed. Tissue must reorganize itself. Cells recruited for an emergency cannot remain indefinitely in emergency mode. Healing therefore requires something that fighting does not: an ending.

Efferocytosis is one of the mechanisms that helps create that ending. I find that idea increasingly compelling because it changes how we think about biological resilience. Health is not simply the ability to resist damage. No organism can do that indefinitely. Cells will die. DNA will be injured. Proteins will misfold. Infections will occur. Tissues will be stressed. The question is what happens afterward.

Your Body Is Not a Static Thing

We often imagine ourselves as collections of permanent structures. My heart. My skin. My lungs. My brain. But the apparent stability of a body conceals astonishing turnover. Cells disappear and are replaced. Molecules are dismantled and rebuilt. Immune cells patrol tissues, respond to disturbances, and then change state again. The continuity we experience is constructed from constant replacement.

Perhaps that is why the biology of cleanup has been relatively easy to overlook. Successful removal leaves almost nothing to see. There is no scar, no fever, no dramatic symptom announcing that a macrophage has just engulfed a cell that no longer belongs. The evidence of success is absence. No inflammation. No accumulation. No alarm. Just tissue continuing to function as though nothing happened.

Researchers are now investigating whether manipulating efferocytosis might eventually help treat inflammatory and age-related diseases. That possibility is intriguing, but much of this work remains mechanistic or preclinical. We are considerably better at describing the cleanup machinery than at safely turning it into therapies. For now, the more interesting lesson may be the simpler one.

Every day, enormous numbers of cells reach the end of their lives inside us. Most disappear without ceremony because another cell recognizes what has happened, carries away the remains, and helps restore quiet. With age, that clearance can become less efficient. The reasons appear to involve changes in the macrophages themselves as well as the inflammatory and metabolic environments in which they work. The biology is still being unraveled, but the larger principle is already striking: resilience depends not only on responding to damage, but on resolving it.

We spend a great deal of time thinking about how the body fights. Some of its most impressive work begins when the fighting is over.

If you enjoy exploring the hidden biology behind how we age, recover, and maintain our capacity, I explore one question like this each week in The Capacity Report. You can join me here.